In vitro susceptibility of Pythium insidiosum to macrolides and tetracycline antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3588-3590

  Loreto, Érico Silva ^a   Mario, Débora Alves Nunes ^a   Denardi, Laura Bedin ^a   Alves, Sydney Hartz ^a   Santurio, Janio Morais ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AZITHROMYCIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; MINOCYCLINE; OXYTETRACYCLINE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OOMYCETES; PRIORITY JOURNAL; PYTHIUM INSIDIOSUM; READING;

ANTI-BACTERIAL AGENTS; ERYTHROMYCIN; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PYTHIUM; TETRACYCLINE;

EID: 79959236524     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01586-10     Document Type: Article

References (22)

1. Argenta, J. S., et al. 2008. In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil. Antimicrob. Agents Chemother. 52:767-769.
2. Cavalheiro, A. S., et al. 2009. In vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum. Antimicrob. Agents Chemother. 53:2136-2138.
3. Cavalheiro, A. S., et al. 2009. In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosum. Vet. Microbiol. 137:408-411.
4. Chambers, H. F., and D. H. Deck. 2009. Tetracyclines, macrolides, clindamycin, chloramphenicol, streptogramins, and oxazolidinones, p. 795-806. In B. G. Katzung, S. B. Masters, and A. J. Trevor (ed.), Basic and clinical pharmacology, 11th ed. McGraw-Hill Medical, New York, NY.
5. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard, 2nd ed. M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Derouin, F., B. Caroff, F. Chau, P. Prokocimer, and J. J. Pocidalo. 1992. Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Antimicrob. Agents Chemother. 36:2852-2855.
7. Gaastra, W., et al. 2010. Pythium insidiosum: an overview. Vet. Microbiol. 146:1-16.
8. Grooters, A. M., and M. K. Gee. 2002. Development of a nested polymerase chain reaction assay for the detection and identification of Pythium insidiosum. J. Vet. Intern. Med. 16:147-152.
9. Krajaejun, T., et al. 2006. Clinical and epidemiological analyses of human pythiosis in Thailand. Clin. Infect. Dis. 43:569-576.
10. Lass-Florl, C., and A. Mayr. 2007. Human protothecosis. Clin. Microbiol. Rev. 20:230-242.
11. Lew, M. A., K. M. Beckett, and M. J. Levin. 1977. Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. J. Infect. Dis. 136:263-270.
12. Lin, Q. H., K. Katakura, and M. Suzuki. 2002. Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline. FEBS Lett. 515:71-74. (Pubitemid 34273900)
13. Meletiadis, J., J. F. G. M. Meis, J. W. Mouton, J. P. Donnelly, and P. E. Verweij. 2000. Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl- 2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J. Clin. Microbiol. 38:2949-2954.
14. Nguyen, M. H., C. J. Clancy, Y. C. Yu, and A. S. Lewin. 1997. Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species. Eur. J. Clin. Microbiol. 16:846-848.
15. Pereira, D. I. B., et al. 2007. Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals. J. Antimicrob. Chemother. 60:1168-1171.
16. Rawn, C. D., and M. Schwarz. 1987. Protection of Pythium species against antibacterial antibiotics by cholesterol. Phytopathology 77:319-323.
17. Rawn, C. D., and J. L. Vanetten. 1978. Mechanism of antibacterial antibiotic sensitivity in Pythium ultimum. J. Gen. Microbiol. 108:133-139.
18. Riviere, J. E. 2009. Tetracycline antibiotics, p. 895-914. In J. E. Riviere and M. G. Papich (ed.), Veterinary pharmacology and therapeutics, 9th ed. Wiley-Blackwell, Ames, IA.
19. Santurio, J. M., S. H. Alves, D. B. Pereira, and J. S. Argenta. 2006. Pythiosis: an emergent mycosis. Acta Sci. Vet. 34:1-14.
20. Santurio, J. M., et al. 2003. Three types of immunotherapics against pythiosis insidiosi developed and evaluated. Vaccine 21:2535-2540. (Pubitemid 36561346)
21. Shenep, J. L., et al. 1998. Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child. Clin. Infect. Dis. 27:1388-1393.
22. Shi, W. N., et al. 2010. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res. 10:885-893.